Skip to main content
BMC Pregnancy and Childbirth logoLink to BMC Pregnancy and Childbirth
. 2025 Mar 14;25:286. doi: 10.1186/s12884-025-07385-7

Association between dietary intakes and pregnancy complications: a two-sample Mendelian randomization analysis

Zengle Zhao 1,2, Tongmin Chang 2, Xiaoyan Liu 3, Xuening Zhang 2, Xinjie Liu 2, Yuan Zhang 2, Jiaqi Chen 2, Yuan Zhang 1,4,, Ming Lu 1,4,
PMCID: PMC11908085  PMID: 40087593

Abstract

Background

Previous studies reported possible connections between dietary factors and pregnancy complications; however, confounders tend to confound the results. A two-sample Mendelian randomization (MR) study was carried out to explore the impact of dietary intakes on the risk of pregnancy complications.

Methods

Exposure data in this study were derived from the IEU Open GWAS project, and the outcome data were from the FinnGen study. The inverse variance-weighted (IVW) method is the main analytical method used in this study. In addition, we verified the accuracy of the findings by performing sensitivity analyses using other methods.

Results

After rigorous False Discovery Rate (FDR) correction, dried fruit intake can reduce the risk of ectopic pregnancy (OR [odds ratio]: 0.36, 95% CI [confidence interval]: 0.21–0.62). Fresh fruit intake was positively associated with pregnancy hypertension (OR: 2.26, 95% CI: 1.32–3.87), and cheese intake was negatively related to pregnancy hypertension (OR: 0.63, 95% CI: 0.47–0.85). In addition, cheese intake was negatively associated with pre-eclampsia (OR: 0.53, 95% CI: 0.38–0.72) and gestational diabetes (OR: 0.48, 95% CI: 0.36–0.64). There was no significant causality in this study for the analyses of other dietary intakes and pregnancy complications, and no heterogeneity or horizontal pleiotropy was found.

Conclusions

Our two-sample MR study explores the causal association between dietary intakes and pregnancy complications, and our results contribute to the primary prevention of pregnancy complications. The mechanism by which dietary intakes affects pregnancy complications can be validated by further basic observational studies.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12884-025-07385-7.

Keywords: Dietary intakes, Pregnancy complications, Mendelian randomization

Introduction

Complications of pregnancy are one of the common health problems of pregnant women, which are non-pregnant conditions that occur before or during pregnancy and may cause significant harm to maternal, fetal, and infant health, including ectopic pregnancy, pregnancy hypertension, pre-eclampsia, gestational diabetes, intrahepatic cholestasis in pregnancy, spontaneous abortion, and premature delivery [1]. Ectopic pregnancy occurs in 1–2% of pregnancies and is a leading cause of maternal mortality during the first trimester [2]. It is responsible for 75% of early pregnancy-related deaths and up to 8% of maternal deaths worldwide [3]. From 1990 to 2021, the global incidence of pregnancy hypertension rose from 31.33 million to 36.10 million cases, marking a 15.24% increase. Meanwhile, its prevalence skyrocketed from 6.15 million to 36.10 million cases, reflecting a dramatic 487% rise [4]. Pre-eclampsia alone causes approximately 46,000 maternal deaths and 500,000 fetal deaths worldwide each year [5]. Additionally, a report indicates that 12.8% of pregnant women globally are affected by gestational diabetes [6]. Intrahepatic cholestasis of pregnancy, a common liver disorder, affects between 0.5% and 1.5% of pregnancies in Europe [7]. Spontaneous abortion occurs in an estimated 12–24% of clinically recognized pregnancies [8]. The estimated global prevalence of premature delivery in 2020 was approximately 9.9%, while the rate in Central Asia was slightly lower, at about 7.9% [9].

The health of the pregnant woman herself can be significantly affected by her behavior during pregnancy. Inadequate care during this period can result in adverse consequences and potential negative effects [10]. For instance, maternal diet is associated with the incidence of gestational diabetes, in addition to fruit being an independent protective factor against pre-eclampsia [11, 12].

Studies have conducted comprehensive GWAS on food preferences in over 150,000 individuals, providing strong evidence that food preferences are influenced not only by culture and familiarity but also by significant biological factors [13]. Pre-pregnancy and pregnancy diets are also one of the key concerns identified by the World Health Organization (WHO). The majority of research on optimal pregnancy outcomes has centered on dietary intakes for pregnant women, such as nutrient consumption and the influence of diet on pregnancy [14]. Nutritional status during pregnancy can have an impact on maternal health. However, there is no conclusive evidence on which specific diets are beneficial during pregnancy [15]. Although some studies have investigated the influence of dietary risk factors on pregnancy complications, the majority of nutritional epidemiological studies have utilized food frequency questionnaires (FFQ) to assess intake, an approach that is prone to bias because of self-reported measurement error by subjects. Consequently, there is inadequate evidence to definitively establish a causal relationship between diet and pregnancy complications [16, 17].

The randomized controlled trial (RCT) is widely recognized as the most reliable method for establishing causality. However, RCTs are often difficult to implement due to a variety of factors such as technical limitations, research methodology, ethical considerations, and other objective factors. In light of these challenges, Mendelian randomization (MR) has been identified as a potential approach to tackle this problem [18, 19]. The advantage of MR over other studies is the use of genetic variants as an instrumental variable (IV) [20]. The principle of genetic variation in which parental genotypes are randomly assigned to offspring is followed in MR analyses, causal sequences are maintained, and common external confounders do not affect the association between exposure and outcome [21].

It is widely acknowledged that understanding the influence of dietary intakes on the risk of experiencing pregnancy complications can improve the knowledge of pregnant women regarding the link between diet and pregnancy complications and can also provide them with valuable dietary recommendations. Therefore, the exposures in our study were studied using a genome-wide association study sourced from the IEU Open GWAS program. The dataset encompassed a range of exposure variables, such as tea intake, alcohol intake frequency, coffee intake, cereal intake, bread intake, fresh fruit intake, dried fruit intake, milk intake, cheese intake, and oily fish intake. The outcome data were obtained through the FinnGen study. This study investigated the association between dietary intakes and pregnancy complications, offering credible evidence for the primary prevention of pregnancy complications.

Methods

Data sources

The exposures and outcomes in this study were from European-descent individuals. Exposures are genome-wide association study (GWAS) summary statistics related to dietary intake that will be obtained from the UK Biobank through the IEU Open Project (https://gwas.mrcieu.ac.uk/). GWAS summary statistics on pregnancy complications were obtained from version R9 of the Finnish Genetic Research Project (https://www.finngen.fi/en), released on May 11, 2023, integrating data from the Finnish Biobank and the Finnish Health Registry. This integration provides a unique entry point for studying disease-associated genetic variants in different populations [22]. Further details regarding the exposure and outcome datasets can be found in Tables 1 and 2, and Additional file 1: Table S1.

Table 1.

Information on the dietary intakes datasets

IEU GWAS ID Exposures Number of IVs Sample size
ukb-b-6066 Tea intake 41 447,485
ukb-b-5779 Alcohol intake frequency 91 462,346
ukb-b-5237 Coffee intake 76 428,860
ukb-b-15,926 Cereal intake 38 441,640
ukb-b-11,348 Bread intake 30 452,236
ukb-b-3881 Fresh fruit intake 50 446,462
ukb-b-16,576 Dried fruit intake 39 421,764
ukb-b-2966 Milk intake 5 64,943
ukb-b-1489 Cheese intake 59 451,486
ukb-b-2209 Oily fish intake 59 460,443

Abbreviation: IEU, Integrative Epidemiology Unit. GWAS, Genome-Wide Association Studies. IV: Instrumental Variable

Table 2.

Information on the pregnancy complications datasets

FinnGen ID Outcomes Cases Controls Sample size Consortium
O15_PREG_ECTOP Ectopic pregnancy 5,648 149,622 155,270 FinnGen
O15_HYPTENSPREG Pregnancy hypertension 14,727 196,143 210,870 FinnGen
O15_PREECLAMPS Pre-eclampsia 6,663 194,266 200,929 FinnGen
GEST_DIABETES Gestational diabetes 13,039 197,831 210,870 FinnGen
O15_ICP_WIDE Intrahepatic Cholestasis of Pregnancy 2,503 130,682 133,185 FinnGen
O15_ABORT_SPONTAN Spontaneous abortion 16,906 149,622 166,528 FinnGen
O15_PRETERM Premature delivery 8,507 162,777 171,284 FinnGen

Selection of IVs

The rationale for the MR analysis and the three hypotheses for the IVs are as follows [23]: (1) IVs are not associated with any confounders; (2) IVs are associated with exposure factors; (3) IVs were not associated with the outcome and could only be associated with the outcome through exposure. The three assumptions above are shown in Fig. 1 (A). We will use a Two-sample MR analysis with exposure and outcome data from different GWAS summary statistics for causal effect analysis, and the flow of the study is shown in Fig. 1 (B).

Fig. 1.

Fig. 1

(A) Study Design Chart. (B) Study Flowchart

SNPs significantly associated with dietary intakes need to be selected as IVs in MR analyses, with the following criteria: (1) Selection of SNPs smaller than the genome-wide threshold of significance level (P < 5 × 10− 8); (2) To prevent chaining imbalances between the included IVs, it is necessary to set the clumping window > 10,000 kb and the linkage disequilibrium (R2 < 0.01); (3) In order to reduce the potential for weak instrumental variable bias and to establish a robust relationship between the IV and the exposure, it is necessary for the F-statistic to exceed 10 [24].

Statistical analysis

To investigate causality, we employed five MR approaches: inverse variance weighting (IVW), MR-Egger regression, weighted median, weighted model, and simple mode. In MR analysis, IVW is considered to be the most robust method for determining causality and is the main method used to estimate causality [25]. The IVW method integrates exposure and outcome in a regression analysis for each genetic variant through correlation, assuming no horizontal pleiotropy, ensuring that the results obtained from IVW are unbiased [26, 27]. The MR-Egger method is not required to satisfy the exclusion-restricted assumption but simply needs to fulfill the Instrument Strength Independent of Direct Effect (InSIDE) assumption that the direct effects of the IVs on the outcome are independent of the associated effect of the IVs on the exposure. Despite potential issues of low power and precision in MR-Egger, the results are considered reliable even in the presence of biases such as multidirectional effects [28, 29]. Since the weighted median method pools data from all genetic variants, it only requires the majority of the variants to be valid in comparison to the IVW analysis. The weighted median method tends to have higher finite-sample Type I error rates, making it a valuable complement to the IVW and MR-Egger regression methods [30, 31]. If the InSIDE assumption is not met, the weighted median method demonstrates greater efficacy in identifying causal effects, with a smaller bias compared to MR-Egger regression.

In addition, we conducted a sensitivity analysis to evaluate the robustness of the association. If the instrumental variables exhibit horizontal pleiotropy, it violates the independence and exclusivity assumptions, two of the three core assumptions. This means that the instruments may affect the outcome through pathways unrelated to the exposure, which could lead to biased IVW estimates. This can be mitigated by incorporating a “non-zero” intercept in the regression of the outcome on the exposure, which accounts for directional horizontal pleiotropy. In MR-Egger, the intercept estimate reflects the average pleiotropic effect across all variants, while the slope provides the causal effect after adjusting for pleiotropy [32]. We use the MR-Egger intercept test to evaluate the average pleiotropic effect and apply the MR-PRESSO method to identify and correct horizontal pleiotropy outliers, thus addressing the bias in MR estimates caused by horizontal pleiotropy. MR-PRESSO provides a comprehensive test to calculate the p-value for overall horizontal pleiotropy. When abnormal p-values are detected for specific SNPs, these variants are systematically removed one by one until the p-value exceeds 0.05. This iterative process ensures the validity of subsequent MR analyses [29]. If heterogeneity is present in the study, it would violate the exclusivity assumption, one of the three core assumptions of MR. Heterogeneity was assessed using the p-value from Cochran’s Q-statistic test, which measures whether differences in effect sizes among the selected genetic variants are due to genuine variations between SNPs rather than sampling error. A p-value less than 0.05 suggests the presence of heterogeneity [33]. Additionally, the leave-one-out analysis tactic was carried out to ascertain whether the causal associations were influenced by any single SNP.

In the case of multiple testing, we calculated the false discovery rate (FDR) for each of the main analyses and adjusted the P values. This study uses FDR correction, which is a relatively mild correction method, rather than simply dividing the threshold α of a single test by the number of tests n. The most common approach is to adjust each p-value and convert it into a q-value. The formula is q = p * n / rank, where rank refers to the position of the p-value in the sorted order from smallest to largest [34]. This algorithm is also known as the Benjamini-Hochberg (BH) procedure. The correlation is considered significant only when P− FDR<0.05, while P values below 0.05, uncorrected for FDR, may suggest a potential causal association but are not deemed statistically significant [34]. The FDR correction in this study was performed for different pregnancy complications, which could better control the false positive rate and maintain the statistical detection ability.

The study was adhered to the STROBE-MR guide-lines (Additional File 3: STROBE-MR) [35]. All statistical analyses were performed using R (version 4.3.1). MR analyses were performed using the TwoSampleMR package (version 0.5.6) [36].

Results

Our study explores genetically predicted causal associations between 10 different dietary intakes and 7 pregnancy complications from a genetic perspective. A set of 450 SNPs was employed as IVs for the 10 dietary intakes exposures according to the IVs screening criteria (all F statistic > 10). Our MR test showed no heterogeneity or horizontal pleiotropy. No other anomalous SNPs were found in subsequent sensitivity analyses. The resultant IVs were analyzed by MR, and the results of the MR analysis are shown in Table S2-8.

Ectopic pregnancy

Among the factors of dietary intake that were studied, it was found that dried fruit intake was negatively correlated with ectopic pregnancy and reduced the risk of disease (OR: 0.36, 95% CI: 0.21–0.62, P < 0.001, FDR < 0.001, IVW). No significant results were found between the other exposures in this study and ectopic pregnancy. (Fig. 2)

Fig. 2.

Fig. 2

The results of the MR analysis of the association between dietary intakes and ectopic pregnancy (P < 5 × 10− 8)

Pregnancy hypertension

By MR analysis, this study found that fresh fruit intake and cheese intake were associated with pregnancy hypertension. Fresh fruit intake showed a positive causal association (OR: 2.26, 95% CI:1.32–3.87, P: 0.003, FDR: 0.018, IVW), and cheese intake showed a negative causal association (OR: 0.63, 95% CI: 0.47–0.85, P: 0.003, FDR: 0.018, IVW). Furthermore, a causal relationship was not identified between the remaining dietary intakes and pregnancy hypertension. (Fig. 3)

Fig. 3.

Fig. 3

The results of the MR analysis of the association between dietary intakes and pregnancy hypertension (P < 5 × 10− 8)

Pre-eclampsia

The study analyzed the relationship between exposure and pre-eclampsia and found only one statistically significant result, that is, cheese intake as a protective factor showed a negative association with pre-eclampsia (OR: 0.53, 95% CI: 0.38–0.72, P < 0.001, FDR < 0.001, IVW). (Fig. 4)

Fig. 4.

Fig. 4

The results of the MR analysis of the association between dietary intakes and pre-eclampsia (P < 5 × 10− 8)

Gestational diabetes

The results showed a negative causal association between the development of gestational diabetes and cheese intake (OR: 0.48, 95% CI: 0.36–0.64, P < 0.001, FDR < 0.001, IVW). Alcohol intake frequency and coffee intake were judged to be nonsignificant results due to the inconsistent direction of the results of the sensitivity analysis. (Additional file 1: Table S5) The results don’t show any other associations. (Fig. 5)

Fig. 5.

Fig. 5

The results of the MR analysis of the association between dietary intakes and gestational diabetes (P < 5 × 10− 8)

Potential causal relationship

Some statistically significant results, after correction for FDR, we did not find a genetic correlation between dietary factors and these pregnancy complications (P < 0.05, FDR > 0.05), suggesting that there may be some suggestive causal relationship. For example, coffee intake and intrahepatic cholestasis of pregnancy; dried fruit intake and spontaneous abortion, premature delivery, etc.

Sensitivity analyses

To strengthen the robustness and reliability of our causal inferences, we conducted various sensitivity analyses. Firstly, we evaluated heterogeneity and pleiotropy using multiple methods, including Cochran’s Q statistic, Egger-intercept, and MR-PRESSO, and chose the most suitable primary analysis approach depending on the specific circumstances. Secondly, to validate the robustness of the primary findings, we utilized four supplementary MR methods: MR-Egger regression, weighted mode, simple mode, and weighted median method. These methods yielded consistent causal estimates in both magnitude and direction (Figs. 2, 3, 4 and 5, Additional File 1: Table S2-8). Thirdly, Cochran’s Q test did not detect heterogeneity, and no pleiotropic effect was observed using the MR-Egger regression, MR-PRESSO test, or MR-Egger intercept test, which also revealed no directional pleiotropic effects (Figs. 2, 3, 4 and 5, Additional File 1: Tables S2-8). Fourthly, the leave-one-out analysis yielded consistent results, indicating that the causal effects were not influenced by any individual SNP (Additional file 2: Figure S9-13). In addition, the scatter plot provided visual displays of the causality of dietary intakes on pregnancy complications risk (Additional file 2: Figure S2-8).

Discussion

Our study used two-sample MR to explore genetic causal associations between 10 dietary intakes and 7 pregnancy complications. By using large-scale GWAS summary statistics, our study draws several conclusions: (1) dried fruit intake is negatively associated with ectopic pregnancy, (2) fresh fruit intake is positively associated with pregnancy hypertension, (3) cheese intake is negatively associated with pregnancy hypertension, pre-eclampsia, and gestational diabetes.

A study presented the results of a GWAS on food preferences conducted in 161,625 participants from the UK Biobank. When compared to corresponding food consumption traits, a high genetic correlation was observed, with preferences exhibiting twice the heritability [13]. The GWAS analysis identified 1,401 significant associations with food preferences, which showed consistent effect directions across 11 independent cohorts [37]. Studies have also suggested that since dietary factors influence epigenetic variations, using dietary compounds to target epigenetic modifications could be valuable in preventing and treating diseases such as cancer [38]. Another twin study found that food preferences have a moderate genetic basis during late puberty. This suggests that common environmental factors influencing food preferences in childhood may not have a lasting impact into adulthood [39].

Our findings suggest that dried fruits have a negative causal association with ectopic pregnancy, which is characterized by the implantation of a fertilized ovum outside the uterine cavity, affecting 5-10% of pregnancies [40]. Ectopic pregnancy has a substantial influence on maternal morbidity and mortality worldwide. Its characteristic symptoms include abdominal pain and vaginal bleeding, with inflammation or infection of the fallopian tubes being the most prevalent cause of ectopic pregnancy [41]. Some countries recommend that pregnant women adhere to a “prudent” dietary pattern that incorporates dried fruits [42, 43]. Dried fruits have high nutritional value and serve as a rich source of micronutrients, including vitamin A, folate, and iron [44]. which are rich in a variety of phytochemicals and bioactive components (i.e. polyphenols, flavonoids) that can influence the development of disease by affecting metabolic pathways and cellular responses. In a study of trends in the global burden of ectopic pregnancy, it was shown that iron deficiency may contribute to the development of ectopic pregnancy [45]. Neisseria gonorrhoeae is a cause of tubal injury, and the pathogen-specific regulator, MpeR, increases the expression of the siderophore receptor FetA in conditions of iron deficiency [46]. Vitamin A deficiency will tend to the keratinization of the endothelium in the fallopian tubes, reducing the likelihood of successful implantation of a fertilized ovum in the uterus [47]. Additionally, animal studies have demonstrated that retinoic acid enhances the developmental capacity of bovine oocytes [48]. Our findings align with prior research indicating that dietary intakes may be modifiable factors contributing to ectopic pregnancy.

This study suggests that a higher intake of fresh fruit may be associated with an increased incidence of pregnancy hypertension. The risk of developing gestational hypertension and pre-eclampsia showed a negative causal association with genetically predicted cheese intake. High blood pressure that develops after the 20th week of pregnancy is called gestational hypertension [49], which usually increases the probability of maternal cardiovascular disease [50]. Elevated blood pressure during pregnancy with proteinuria (≥ 300 mg/d) was defined as pre-eclampsia. These two complications are among the most common complications of pregnancy, affecting approximately 15% of all pregnancies worldwide [51, 52]. It is well known that consuming high-GI fruits can lead to increased blood glucose levels in the body, and a longitudinal study has demonstrated that elevated glucose serves as an independent risk factor for the development of hypertension [53]. The possible mechanisms are as follows: (1) Alteration of the Renin-Angiotensin System: Elevated blood glucose may alter the renin-angiotensin system, which can result in changes to blood pressure levels [54]; (2) PKC-Mediated Vascular Smooth Muscle Contraction: Elevated glucose levels trigger PKCα/PKCβ-mediated suppression of Kv electrical currents in vascular smooth muscle, leading to an increased contractile response, which can raise blood pressure [55]; (3) Oxidative Stress and Vascular Damage: Oxidative stress caused by high blood glucose contributes to vascular remodeling and inflammation, which ultimately causes vascular damage and exacerbates hypertension [56]. The present study demonstrated a negative causal relationship between cheese intake and the development of gestational hypertension and preeclampsia, consistent with previous findings [57, 58]. This can be explained by the following mechanism: Firstly, Calcium and Fatty Acids Interaction: Cheese is rich in calcium, which interacts with fatty acids in the gastrointestinal tract to form insoluble soaps. This interaction negatively correlates with total cholesterol and LDL levels, ultimately inhibiting the absorption of fatty acids [59]. Secondly, Anti-inflammatory Protein Components: Cheese contains proteins such as casein, α-lactalbumin, and β-lactoglobulin, which are dairy proteins that have beneficial effects on inflammation [60].

Our study took a genetic approach to establish causality using MR studies and showed a negative causal association with gestational diabetes. The idea that increasing cheese intake during pregnancy reduces the risk of gestational diabetes has been demonstrated in previous studies [61, 62]. Gestational diabetes refers to the initial onset of diabetes or abnormal glucose tolerance during pregnancy [63], and affects 15-20% of the world’s pregnancies. Gestational diabetes increases the risk of other complications in pregnant women, leading to possible epigenetic changes in the new generation and increasing the chances of obesity and type 2 diabetes [64]. Our findings can be explained by two aspects. On the one hand, uncontrolled insulin secretion during pregnancy leads to the production of lipid peroxidation factors and the body is in a state of oxidative stress, which can be reduced by the higher amount of nutrients in cheese (proteins, calcium, zinc, vitamins, probiotics, etc.) [65]. On the other hand, cheese intake not only counteracts the negative effects of its high saturated fatty acids, but the lactobacilli in cheese also maintain the balance of the intestinal flora, which is beneficial in gestational diabetes [66, 67]. Although the use of MR analysis can be effective in addressing biases caused by confounding variables, it should be noted that MR analysis should be viewed as an important complement to, and not a substitute for randomized controlled trials and descriptive studies. Consequently, it is advisable to interpret the findings of this study with caution [68].

The results of this study suggest that dietary interventions can strengthen maternal health education and improve nutritional management during pregnancy, thereby reducing the occurrence of pregnancy complications and enhancing the quality of life and well-being of pregnant women. However, in clinical practice, dietary interventions should consider factors such as individual genetic background, cultural differences, and lifestyle. Pregnancy complications are influenced by multiple factors. Therefore, it is recommended that the findings of this study be used as supplementary evidence, rather than the sole basis for clinical decision-making. Future research should further validate these associations and assess the effectiveness of dietary recommendations in more diverse populations to ensure their feasibility and accuracy in clinical practice. Additionally, it is suggested that systematic screening be conducted early in pregnancy to identify women at risk for diet-related complications and provide early intervention. Current research on the impact of dietary intake on pregnancy complications is still incomplete, and the underlying mechanisms need to be further explored in future animal experiments and observational studies.

Our study possesses several notable advantages. First, the study explores the causal relationship between dietary intake and pregnancy complications through MR analysis, which effectively eliminates confounding factors that may influence this relationship. The use of a reasonable time sequence in causal inference ensures the reliability of our conclusions. Second, the F-statistics for each exposure exceed 10, which helps avoid weak instrument bias. Third, our study participants were exclusively of European descent, which mitigates the potential for population stratification bias. Finally, we conducted Cochran’s Q statistic and comprehensive pleiotropy tests to assess heterogeneity and pleiotropic effects. Outliers were detected and removed using the MR-PRESSO method, further ensuring the robustness of our findings.

Moreover, this study has certain limitations. First, we used data at the summary level and the individual-level data were not available, for example, we could not know the type of fresh fruit intake (e.g., high-GI fruits such as mango and pineapple honey or low-GI fruits such as grapefruit and oranges), family history of pregnancy hypertension in pregnant women, and relevant medical history of the study participants at baseline, and we were therefore unable to examine the presence of nonlinear causality between dietary intakes and the risk of pregnancy complications. Second, the analysis was primarily conducted on individuals of European ancestry, which may limit the generalizability of the findings to other populations. Genetic structure and environmental factors may vary significantly across different populations, potentially leading to differences in health outcomes. Third, we endeavored to identify multiple dietary intakes patterns, yet we encountered challenges in discerning specific effects under various dietary combinations. Further research is therefore necessary to explore these issues.

Conclusions

This study revealed a negative association between dried fruit intake and ectopic pregnancy. Fresh fruit intake is positively associated with pregnancy hypertension. Cheese intake is negatively related to pregnancy hypertension, pre-eclampsia, and gestational diabetes. In summary, future studies on the association between pregnancy complications and diet should utilize multiple genomic platforms to explore genetic effects in combination with environmental synthesis. Our findings are informative for the primary prevention of pregnancy complications, but further research is needed to explore these relationships before dietary intakes recommendations can be made.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1 (227.3KB, docx)
Supplementary Material 3 (42.7KB, docx)

Acknowledgements

The authors acknowledge the participants and investigators of the IEU Open Project study and FinnGen study.

Abbreviations

FDR

False Discovery Rate

FFQ

Food Frequency Questionnaires

GWAS

Genome-Wide Association Studies

IEU

Integrative Epidemiology Unit

IV

Instrumental Variable

IVW

Inverse Variance-Weighted

MR

Mendelian Randomization

RCT

Randomized Controlled Trial

SNP

Single-nucleotide Polymorphism

WHO

World Health Organization

Author contributions

Data collection, data curation, Methodology, Formal analysis, Software, and Visualization were performed by ZZ, TC, XL, XZ, JC, YZ, and XL. Writing original draft: ZZ, YZ. Funding acquisition: ML. Writing review and editing: YZ, XL, and ML. The corresponding authors attest that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.

Funding

This work was supported by the Shandong Provincial Medical Association (YXH2022PT06001), ECCM Program of Clinical Research Center of Shandong University (2021SDUCRCE001) and the TaiShan Scholars (tstp20230654).

Data availability

This study uses publicly available datasets, which can be found in the IEU Open Project (https://gwas.mrcieu.ac.uk/), and the FinnGen study (https://www.finngen.fi/en).

Declarations

Ethics approval and consent to participate

Data for this study were obtained from published databases, and informed consent and ethical review approval were obtained in the original study.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Yuan Zhang, Email: zhangyuan@qiluhospital.com.

Ming Lu, Email: lvming@sdu.edu.cn.

References

  • 1.McNestry C, Killeen SL, Crowley RK, McAuliffe FM. Pregnancy complications and later life women’s health. Acta Obstet Gynecol Scand. 2023;102:523–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Chong KY, de Waard L, Oza M, van Wely M, Jurkovic D, Memtsa M, et al. Ectopic pregnancy. Nat Rev Dis Primers. 2024;10:94. [DOI] [PubMed] [Google Scholar]
  • 3.Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2:e323–33. [DOI] [PubMed] [Google Scholar]
  • 4.Sun S, Li W, Zhang X, Aziz AUR, Zhang N. Trends in global and regional incidence and prevalence of hypertensive disordersin pregnancy (1990–2021): an age-period-cohort analysis. Sci Rep. 2025;15:1513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.GBD 2015 Maternal Mortality Collaborators. Global regional and national levels of maternal mortality, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1775–812. [DOI] [PMC free article] [PubMed]
  • 6.Lin X, Zhou L, Si S, Cheng H, Alifu X, Qiu Y, et al. Association of the comorbidity of gestational diabetes mellitus and hypertension disorders of pregnancy with birth outcomes. Front Endocrinol (Lausanne). 2024;15:1468820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Axelsen SM, Schmidt MC, Kampmann U, Grønbæk H, Fuglsang J. The effect of twin pregnancy in intrahepatic cholestasis of pregnancy: A case control study. Acta Obstet Gynecol Scand. 2024;103:1994–2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wang YX, Mínguez-Alarcón L, Gaskins AJ, Missmer SA, Rich-Edwards JW, Manson JE et al. Association of spontaneous abortion with all cause and cause specific premature mortality: prospective cohort study. Bmj. 2021;372:n530. [DOI] [PMC free article] [PubMed]
  • 9.Ohuma EO, Moller AB, Bradley E, Chakwera S, Hussain-Alkhateeb L, Lewin A, et al. National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet. 2023;402:1261–71. [DOI] [PubMed] [Google Scholar]
  • 10.Hayes L, McParlin C, Azevedo LB, Jones D, Newham J, Olajide J et al. The effectiveness of smoking cessation, alcohol reduction, diet and physical activity interventions in improving maternal and infant health outcomes: a systematic review of meta-analyses. Nutrients. 2021; 13. [DOI] [PMC free article] [PubMed]
  • 11.Endeshaw M, Abebe F, Bedimo M and Asart A. Diet and pre-eclampsia: a prospective multicentre case-control study in Ethiopia. Midwifery. 2015;31:617–24. [DOI] [PubMed]
  • 12.Shin D, Lee KW and Song WO. Dietary patterns during pregnancy are associated with risk of gestational diabetes mellitus. Nutrients. 2015;7:9369–82. [DOI] [PMC free article] [PubMed]
  • 13.May-Wilson S, Matoba N, Wade KH, Hottenga JJ, Concas MP, Mangino M, et al. Large-scale GWAS of food liking reveals genetic determinants and genetic correlations with distinct neurophysiological traits. Nat Commun. 2022;13:2743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mate A, Reyes-Goya C, Santana-Garrido Á, Vázquez CM. Lifestyle, maternal nutrition and healthy pregnancy. Curr Vasc Pharmacol. 2021;19:132–40. [DOI] [PubMed] [Google Scholar]
  • 15.Bhutta ZA, Das JK, Rizvi A, Gaffey MF, Walker N, Horton S, et al. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet. 2013;382:452–77. [DOI] [PubMed] [Google Scholar]
  • 16.Schatzkin A, Kipnis V. Could exposure assessment problems give us wrong answers to nutrition and cancer questions? J Natl Cancer Inst. 2004;96:1564–5. [DOI] [PubMed] [Google Scholar]
  • 17.Tripepi G, Jager KJ, Dekker FW, Zoccali C. Selection bias and information bias in clinical research. Nephron Clin Pract. 2010;115:c94–9. [DOI] [PubMed] [Google Scholar]
  • 18.West SG, Thoemmes F. Campbell’s and Rubin’s perspectives on causal inference. Psychol Methods. 2010;15:18–37. [DOI] [PubMed] [Google Scholar]
  • 19.Steeger CM, Buckley PR, Pampel FC, Gust CJ, Hill KG. common methodological problems in randomized controlled trials of preventive interventions. Prev Sci. 2021;22:1159–72. [DOI] [PubMed] [Google Scholar]
  • 20.Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2000;29:722–9. [DOI] [PubMed] [Google Scholar]
  • 21.Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23:R89–98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. Jama. 2017;318:1925–6. [DOI] [PubMed] [Google Scholar]
  • 24.DS. Instrumental variables regression with weak instruments. Econometrica. 1997;65:557–86. [Google Scholar]
  • 25.Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46:1985–98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med. 2016;35:1880–906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Rees JMB, Wood AM, Dudbridge F, Burgess S. Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates. PLoS ONE. 2019;14:e0222362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32:377–89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal Pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent Estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson J. A framework for the investigation of Pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017;36:1783–802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;45:1961–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Greco MF, Minelli C, Sheehan NA, Thompson JR. Detecting Pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med. 2015;34:2926–40. [DOI] [PubMed] [Google Scholar]
  • 34.Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100:9440–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA. 2021;326:1614–21. [DOI] [PubMed] [Google Scholar]
  • 36.Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D et al. The MR-base platform supports systematic causal inference across the human phenome. Elife. 2018;7. [DOI] [PMC free article] [PubMed]
  • 37.Pallister T, Sharafi M, Lachance G, Pirastu N, Mohney RP, MacGregor A, et al. Food preference patterns in a UK twin cohort. Twin Res Hum Genet. 2015;18:793–805. [DOI] [PubMed] [Google Scholar]
  • 38.Hardy TM. and Tollefsbol TO. Epigenetic diet: impact on the epigenome and cancer. Epigenomics. 2011;3:503–18. [DOI] [PMC free article] [PubMed]
  • 39.Smith AD, Fildes A, Cooke L, Herle M, Shakeshaft N, Plomin R, et al. Genetic and environmental influences on food preferences in adolescence. Am J Clin Nutr. 2016;104:446–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Mullany K, Minneci M, Monjazeb R, CCO. Overview of ectopic pregnancy diagnosis, management, and innovation. Womens Health (Lond). 2023;19:17455057231160349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Farquhar CM. Ectopic pregnancy. Lancet. 2005;366:583–91. [DOI] [PubMed] [Google Scholar]
  • 42.DeSalvo KB, Olson R, Casavale KO. Diet guidelines for Americans. Jama. 2016;315:457–8. [DOI] [PubMed]
  • 43.Yang Y, Yang X, Zhai F. Y. J. J. o. t. A. o. N. Cheng and dietetics dietary guidelines for Chinese (2016). 2016;116:A37-A37.
  • 44.Sadler MJ, Gibson S, Whelan K, Ha MA, Lovegrove J, Higgs J. Dried fruit and public health - what does the evidence tell us?? Int J Food Sci Nutr. 2019;70:675–87. [DOI] [PubMed] [Google Scholar]
  • 45.Zhang S, Liu J, Yang L, Li H, Tang J, Hong L. Global burden and trends of ectopic pregnancy: an observational trend study from 1990 to 2019. PLoS ONE. 2023;18:e0291316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Hollander A, Mercante AD, Shafer WM, Cornelissen CN. The iron-repressed, AraC-like regulator MpeR activates expression of feta in Neisseria gonorrhoeae. Infect Immun. 2011;79:4764–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Clagett-Dame M, Knutson D. Vitamin A in reproduction and development. Nutrients. 2011;3:385–428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Duque P, Díez C, Royo L, Lorenzo PL, Carneiro G, Hidalgo CO, et al. Enhancement of developmental capacity of meiotically inhibited bovine oocytes by retinoic acid. Hum Reprod. 2002;17:2706–14. [DOI] [PubMed] [Google Scholar]
  • 49.Magee LA, and von Dadelszen P. State-of-the-art diagnosis and treatment of hypertension in pregnancy. Mayo Clin Proc. 2018;93:1664–1677. [DOI] [PubMed]
  • 50.Rich-Edwards JW, Fraser A, Lawlor DA, Catov JM. Pregnancy characteristics and women’s future cardiovascular health: an underused opportunity to improve women’s health? Epidemiol Rev. 2014;36:57–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785–99. [DOI] [PubMed] [Google Scholar]
  • 52.Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631–44. [DOI] [PubMed] [Google Scholar]
  • 53.Kuwabara M, Chintaluru Y, Kanbay M, Niwa K, Hisatome I, Andres-Hernando A, et al. Fasting blood glucose is predictive of hypertension in a general Japanese population. J Hypertens. 2019;37:167–74. [DOI] [PubMed] [Google Scholar]
  • 54.Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016;12:144–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Jackson R, Brennan S, Fielding P, Sims MW, Challiss RA, Adlam D, et al. Distinct and complementary roles for α and Β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucose. Br J Pharmacol. 2016;173:870–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Montezano AC, Dulak-Lis M, Tsiropoulou S, Harvey A, Briones AM, Touyz RM. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. Can J Cardiol. 2015;31:631–41. [DOI] [PubMed] [Google Scholar]
  • 57.Hofmeyr GJ, Lawrie TA, Atallah Á N, Torloni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2018;10:Cd001059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Hofmeyr GJ, Betrán AP, Singata-Madliki M, Cormick G, Munjanja SP, Fawcus S, et al. Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2019;393:330–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Jacqmain M, Doucet E, Després JP, Bouchard C, Tremblay A. Calcium intake, body composition, and lipoprotein-lipid concentrations in adults. Am J Clin Nutr. 2003;77:1448–52. [DOI] [PubMed] [Google Scholar]
  • 60.Cifelli CJ. Looking beyond traditional nutrients: the role of bioactives and the food matrix on health. Nutr Rev. 2021;79:1–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Zareei S, Homayounfar R, Naghizadeh MM, Ehrampoush E, Rahimi M. Dietary pattern in pregnancy and risk of gestational diabetes mellitus (GDM). Diabetes Metab Syndr. 2018;12:399–404. [DOI] [PubMed] [Google Scholar]
  • 62.Hinkle SN, Li M, Grewal J, Yisahak SF, Grobman WA, Newman RB, et al. Changes in diet and exercise in pregnant women after diagnosis with gestational diabetes: findings from a longitudinal prospective cohort study. J Acad Nutr Diet. 2021;121:2419–e24284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–97. [DOI] [PubMed] [Google Scholar]
  • 64.Lehnen H, Zechner U, Haaf T. Epigenetics of gestational diabetes mellitus and offspring health: the time for action is in early stages of life. Mol Hum Reprod. 2013;19:415–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Phoswa WN. and Khaliq OP. The role of oxidative stress in hypertensive disorders of pregnancy (Preeclampsia, gestational hypertension) and metabolic disorder of pregnancy (Gestational diabetes mellitus). Oxid Med Cell Longev. 2021;2021:5581570. [DOI] [PMC free article] [PubMed]
  • 66.Thorning TK, Bertram HC, Bonjour JP, de Groot L, Dupont D, Feeney E, et al. Whole dairy matrix or single nutrients in assessment of health effects: current evidence and knowledge gaps. Am J Clin Nutr. 2017;105:1033–45. [DOI] [PubMed] [Google Scholar]
  • 67.Ponzo V, Fedele D, Goitre I, Leone F, Lezo A, Monzeglio C et al. Diet-gut microbiota interactions and gestational diabetes mellitus (GDM). Nutrients. 2019;11. [DOI] [PMC free article] [PubMed]
  • 68.Boyko EJ. Observational research–opportunities and limitations. J Diabetes Complications. 2013;27:642–8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material 1 (227.3KB, docx)
Supplementary Material 3 (42.7KB, docx)

Data Availability Statement

This study uses publicly available datasets, which can be found in the IEU Open Project (https://gwas.mrcieu.ac.uk/), and the FinnGen study (https://www.finngen.fi/en).


Articles from BMC Pregnancy and Childbirth are provided here courtesy of BMC

RESOURCES